COVID-19: FDA issues EUA for convalescent plasma as potential treatment
by Press Release from Outbreak News Today on (#578BK)
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) today for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency's ongoing efforts to fight COVID-19. Based on scientific evidence available, the FDA concluded, as outlined in its decision memorandum, this product may be effective [...]
The post COVID-19: FDA issues EUA for convalescent plasma as potential treatment appeared first on Outbreak News Today.